NO920591L - Substituerte benzofuranylpiperidiner som nootropikum - Google Patents

Substituerte benzofuranylpiperidiner som nootropikum

Info

Publication number
NO920591L
NO920591L NO92920591A NO920591A NO920591L NO 920591 L NO920591 L NO 920591L NO 92920591 A NO92920591 A NO 92920591A NO 920591 A NO920591 A NO 920591A NO 920591 L NO920591 L NO 920591L
Authority
NO
Norway
Prior art keywords
nootropicum
piperidines
substituted benzofuranyl
treatment
disorders
Prior art date
Application number
NO92920591A
Other languages
English (en)
Other versions
NO179358B (no
NO920591D0 (no
NO179358C (no
Inventor
Cesare Mondadori
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO920591D0 publication Critical patent/NO920591D0/no
Publication of NO920591L publication Critical patent/NO920591L/no
Publication of NO179358B publication Critical patent/NO179358B/no
Publication of NO179358C publication Critical patent/NO179358C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO920591A 1991-02-15 1992-02-14 Anvendelse av substituerte benzofuranylpiperidiner som nootropikum NO179358C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH47091 1991-02-15

Publications (4)

Publication Number Publication Date
NO920591D0 NO920591D0 (no) 1992-02-14
NO920591L true NO920591L (no) 1992-08-17
NO179358B NO179358B (no) 1996-06-17
NO179358C NO179358C (no) 1996-09-25

Family

ID=4187740

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920591A NO179358C (no) 1991-02-15 1992-02-14 Anvendelse av substituerte benzofuranylpiperidiner som nootropikum

Country Status (16)

Country Link
EP (1) EP0499586B1 (no)
JP (1) JPH0570352A (no)
KR (1) KR920016098A (no)
AT (1) ATE138805T1 (no)
AU (1) AU655227B2 (no)
CA (1) CA2061015A1 (no)
DE (1) DE59206442D1 (no)
DK (1) DK0499586T3 (no)
ES (1) ES2087497T3 (no)
GR (1) GR3020155T3 (no)
IE (1) IE74906B1 (no)
IL (1) IL100889A (no)
MX (1) MX9200620A (no)
NO (1) NO179358C (no)
NZ (1) NZ241608A (no)
ZA (1) ZA921091B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3595093A (en) * 1992-02-21 1993-09-13 Ciba-Geigy Ag Brofaromine as an agent for treating social phobia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE175358T1 (de) * 1987-10-22 1999-01-15 Massachusetts Inst Technology Behandlung des prämenstruellen oder späten lutealsphase-syndroms

Also Published As

Publication number Publication date
DK0499586T3 (da) 1996-06-24
AU655227B2 (en) 1994-12-08
GR3020155T3 (en) 1996-09-30
JPH0570352A (ja) 1993-03-23
ATE138805T1 (de) 1996-06-15
AU1087792A (en) 1992-08-20
MX9200620A (es) 1992-08-01
NO179358B (no) 1996-06-17
NO920591D0 (no) 1992-02-14
EP0499586B1 (de) 1996-06-05
NO179358C (no) 1996-09-25
ES2087497T3 (es) 1996-07-16
IL100889A (en) 1997-03-18
IE74906B1 (en) 1997-08-13
IE920486A1 (en) 1992-08-26
NZ241608A (en) 1997-06-24
ZA921091B (en) 1992-09-30
EP0499586A1 (de) 1992-08-19
DE59206442D1 (de) 1996-07-11
KR920016098A (ko) 1992-09-24
CA2061015A1 (en) 1992-08-16
IL100889A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
NO931056L (no) Sulfonamido- og sulfonamidokarbonyl-pyridin-2-karboksylsyreamider samt deres pyridin-n-oksider, fremgangsmaater for fremstilling derav og anvendelse av forbindelsene som legemidler
ES2139638T3 (es) 1,4-piperazinas disustituidas para el tratamiento de las enfermedades del sistema nervioso central y de las enfermedades neuroendocrinas.
NO961687L (no) Nye (R)-5-karbamoyl-8-fluor-3-N,N-disubstituerte-amino-3,4-dihydro-2H-1-benzopyraner
NO921609D0 (no) Sulfonamider og deres medisinske anvendelse
NL300006I1 (nl) Imidazolylalkeenzuurderivaten.
DK0734383T3 (da) Cykliske amidderivater som neurokinin-A-antagonister
EP0354777A3 (en) 3-(4-piperidine)-5-(2-sulfonylaminoethyl) indole derivatives
DE69216293D1 (de) 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung
NO941884D0 (no) 1,3-substituerte cykloalkener og cykloalkaner som sentralnervesystem-midler
HUT56077A (en) Process for producing n-(imidazolyl-alkyl)-alanyl derivatives with substituents and pharmaceutical compositions containing them as active components
NO980923L (no) Optisk aktivt fenylpyrimidin-derivat som analgetisk middel
NO952624L (no) Antihyperglykemisk aktivt legemiddel
NO920591D0 (no) Substituerte benzofuranylpiperidiner som nootropikum
PT92671A (pt) Processo para a preparacao de ariloxipropanolaminotetralinas farmaceuticamente activas
NO166788C (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydrobenzofuro(2,3-c)-pyridiner.
SE8603517D0 (sv) Heterocyclic compounds and their preparation and pharmaceutical formulation
ZW6889A1 (en) &-adrenergic receptor antagonists
DK286090A (da) Alfa-adrenerge receptorantagonister
DK0573360T3 (da) Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister